↓: Decrease; ↑: Increase; AUC: Area under the curve ... dosing in treatment-naive patients and has less pharmacokinetic variability compared with other HIV INSTIs. For treatment-naive patients ...

A cross-sectional analysis shows that long-acting antiretroviral therapy sustains viral suppression regardless of initial ...

The campaign is a collaboration between the National Department of Health and the South African National Aids Council.

Although US mortality rates from concurrent HIV and viral hepatitis infection have declined since the late 1990s, gender disparities persist.

The Close the Gap campaign is aimed at urging those defaulting on ARV treatment to return. Reports suggest that over 200,000 ...

People living with HIV are less likely to receive potentially lifesaving cancer treatment if they live in communities with lower income levels and educational attainment, according to a new US ...

French biotech Abivax might be on the verge of HIV cure and prevention discovery, after achieving a significant reduction of viral load patients during the first 28 days of treatment. The company ...

Patients can face a bind: Without therapy, they can’t return to work, but without working, they can’t afford the therapy. Paulo says she pressed her insurer for more sessions, to no avail.

As of 2022, an estimated 50 million people globally were infected with chronic hepatitis C virus (HCV), with an estimated 1 ...

BGF is currently approved under the brand name Breztri Aerosphere for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). The product is a triple combination ...

A man with incurable prostate cancer whose only chance is a “breakthrough therapy” not available for public patients has called on the HSE to help men in his situation. Peter Hayes ...